USPTO Rescinds Controversial Patent Rule Changes Proposed by Prior Administration | GenomeWeb

NEW YORK (GenomeWeb Daily News) – The US Patent and Trademark Office said yesterday that Under Secretary of Commerce for Intellectual Property and Director David Kappos has signed a final rule rescinding highly controversial regulations that were enacted by the USPTO under the Bush administration and were viewed by many in the biotech industry as hindering their ability to protect IP.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.